Information Provided By: 
Fly News Breaks for March 23, 2018
MGLN
Mar 23, 2018 | 09:00 EDT
Investor concern has been rising this week regarding Magellan Health's ability to maintain its Florida Serious Mentally Ill contract that contributes 7% to earnings, Jefferies analyst David Styblo tells investors in a research note. More specifically, investors are worried that Magellan has not been invited to negotiate, the analyst adds. He believes, however, that the company has been invited. While not a guarantee of award, it is a positive indication, Styblo writes. The analyst reiterates a Buy rating on Magellan Health with a $120 price target.
News For MGLN From the Last 2 Days
There are no results for your query MGLN
